Treatment of Overactive Bladder With Anticholinergic Agents

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Status: Active, not recruiting

Conditions: Overactive Bladder

Treatments: Drug: Tolterodine; Drug: propiverine; Drug: Oxybutynin Cl

Study type: Observational

Funder types: Other

Identifiers

NCT07046156

Ivstrh - OAB

Details and patient eligibility

About

This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.

Full description

A total of approximately 150 patients with overactive bladder will be evaluated retrospectively. Clinical and demographic data and voiding diaries of these patients will be evaluated. For this purpose, patients will be divided into mainly three groups according to the anticholinergic agent used.

Enrollment: 120 estimated patients

Sex: All

Ages: 5 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with overactive bladder
• Patients treated with an anticholinergic

Exclusion criteria

• Presence of anatomical or neurological problems
• Patients with missing data

Trial design

120 participants in 3 patient groups

Oxybutynin

Description:

Patients treated with oxybutynin

Treatment:

Drug: Oxybutynin Cl

Propiverine

Description:

Patients treated with propiverine

Treatment:

Drug: propiverine

Tolterodine

Description:

Patients treated with tolterodine

Treatment:

Drug: Tolterodine